Clinical Trials/Medical Discoveries

BioMarin Pharmaceutical Inc. announced today an update in the Phase 2 clinical study of PEG-PAL for the treatment of phenylketonuria . Data reported in this announcemen...

Study indicates that weight control and physical fitness may help reduce the risk of severe gum disease

Cardioxyl Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing novel therapeutic agents for the treatment of cardiovascular disease, today announced ...

Bionovo, Inc. today announced results from studies in neurons of its drug candidate Menerba for the treatment of menopausal hot flashes. The study, published in the Publ...

N30 Pharmaceuticals, LLC today announced the approval of its Investigational New Drug Application for N6022 by the U.S. Food and Drug Administration. N6022, a first-in-c...

Orexigen® Therapeutics, Inc. announced that results from its COR-I trial of Contrave® were published online today in the journal Lancet. COR-I was the largest of the fou...

Scientists atdeCODE genetics and colleagues at Radboud University in the Netherlands todaydescribe how the impact of a single letter variation in the sequence of thehuman...

places in which two chromosomes exchange pieces of themselves. As many as 1 in 600 persons carry balanced chromosome translocations, which involve no loss or gain of DNA....

Intra-Cellular Therapies, Inc. today announced the results from a Phase Ib/II clinical trial in patients with schizophrenia with ITI-007, the Company's unique, inves...

Anthera Pharmaceuticals, Inc. , a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it has initiated PEAR...